The global in vitro diagnostics (IVD) market size was estimated at USD 115.48 billion in 2022 and is expected to hit around USD 124.65 billion by 2032 with a CAGR of 1.6% from 2023 to 2032.

Key Takeaway

• North America Market has captured a revenue share of 42.5% in 2022.
• By product, the reagents segment held a revenue share of 65.8% in 2022.
• By application, the molecular diagnostics segment accounted highest revenue share of 38% in 2022.
• By end-uses, the laboratory segment has captured 40% revenue share in 2022%.
• By test location, the point-of-care segment has generated a market share of over 21% in 2022.
• By application, the infectious disease segment has garnered a revenue share of over 59.50% in 2022.

The report has been prepared with extensive primary and secondary research. Primary research involved the majority of the research efforts, wherein analysts carried out interviews with key manufacturers, end-consumers, industry experts, independent consultants, and opinion-makers.

Secondary research involved referring to company websites, annual reports, investors’ presentations, press releases, patents database, import-export statistics, and other relevant documents to understand the in vitro diagnostics (IVD) Market. Secondary research also included Precedence Research internal repository, industry associations, government agencies, and proprietary databases. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro diagnostics (IVD) market.

Request a Sample Copy of This Report@ https://www.precedenceresearch.com/sample/1130

The report includes an executive summary, along with a market overview and an elaborative analysis of the growth behavior in various segments that are included in the scope of the study. The report also covers a high-level picture of the production processes and product specifications pertaining to in vitro diagnostics (IVD). Furthermore, the report provides insights on the changing competitive dynamics, which serve as valuable tools for existing market players as well as for entities interested in participating in the market.

In addition to the above, the report also explores the competitive landscape, in terms of identifying the global players operating in the in vitro diagnostics (IVD) market and comprehensive profiles of the key players, including their business overview, key financials, market shares, market footprints, production capacities, and strategic initiatives including new product developments, mergers & acquisitions, etc.

Some of the prominent players in the global in vitro diagnostics (IVD) market include:

• Alere, Inc.
• Hoffmann-La Roche Ltd.
• Arkray
• Beckman Coulter
• Becton Disckinson
• Bio-Rad laboratories
• Danaher
• Sysmex Corporation
• Abbott Laboratories

Segments Covered in the Report

By Product

• Reagents
• Instruments
• Services

By Test Location

• Point of Care
• Home Care
• Others

By Technology

• Immunoassay

  • Instruments

  • Reagents

  • Services

• Hematology

  • Instruments

  • Reagents

  • Services

• Clinical Chemistry

  • Instruments

  • Reagents

  • Services

• Molecular Diagnostics

  • Instruments

  • Reagents

  • Services

• Coagulation

  • Instruments

  • Reagents

  • Services

• Microbiology

  • Instruments

  • Reagents

  • Services

• Others

  • Instruments

  • Reagents

  • Services

By Application

• Diabetes
• Cardiology
• Nephrology
• Infectious Disease
• Oncology
• Drug Testing
• Autoimmune Diseases
• Others

By End User

• Standalone Laboratories
• Hospitals
• Academic & Medical Schools
• Point-of-Care
• Others

By Regional

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Middle East & Africa
• Latin America

Research Methodology

Precedence Research employs a comprehensive and iterative research methodology focused on minimizing deviance to provide the most accurate estimates and forecasts possible. The company utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. In Addition, a recurring theme prevalent across all our research reports is data triangulation which looks market from three different perspectives. Critical elements of the methodology employed for all our studies include:

Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For a comprehensive understanding of the market, it is essential to understand the complete value chain, and to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia, and trade journals. Technical data is also gathered from an intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, and pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression, and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, industry experience, and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of the technology landscape, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

• Market drivers and restraints, along with their current and expected impact
    • Raw material scenario and supply v/s price trends
      • Regulatory scenario and expected developments
      • Current capacity and expected capacity additions up to 2030

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
• Company overview
• Financial performance
• Product benchmarking
• Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2017 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. In Vitro Diagnostics (IVD) Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on In Vitro Diagnostics (IVD) Market

5.1. Covid-19: In Vitro Diagnostics (IVD) Industry Impact
5.2. In Vitro Diagnostics (IVD) Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and In Vitro Diagnostics (IVD) Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for In Vitro Diagnostics (IVD) Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global In Vitro Diagnostics (IVD) Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. In Vitro Diagnostics (IVD) Market Revenue by Manufacturer (2017-2021)
7.1.1.2. In Vitro Diagnostics (IVD) Market Revenue Market Share by Manufacturer (2017-2021)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global In Vitro Diagnostics (IVD) Market, By Product Type

8.1. In Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030
8.1.1. Reagents
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global In Vitro Diagnostics (IVD) Market, By Technology

9.1. In Vitro Diagnostics (IVD) Market, By Technology, 2017-2030
9.1.1. Hematology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Molecular Diagnostics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Immunology
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Coagulation
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Clinical Chemistry
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Microbiology
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Other
9.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global In Vitro Diagnostics (IVD) Market, By Application

10.1. In Vitro Diagnostics (IVD) Market, By Application, 2017-2030
10.1.1. Diabetes
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Cardiology
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Nephrology
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Infectious Disease
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Oncology
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Drug Testing
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Autoimmune Diseases
10.1.7.1. Market Revenue and Forecast (2017-2030)
10.1.8. Others
10.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global In Vitro Diagnostics (IVD) Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product (2017-2030)
11.1.2. Market Revenue Forecast By Technology (2017-2030)
11.1.3. Market Revenue Forecast By Application (2017-2030)
11.1.4. Market Revenue Forecast by Technology (2017-2030)
11.1.5. U.S
11.1.5.1. Market Revenue Forecast (2017-2030)
11.1.5.2. Market Revenue Forecast (2017-2030)
11.1.6. Canada
11.1.6.1. Market Revenue Forecast (2017-2030)
11.1.6.2. Market Revenue Forecast (2017-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2017-2030)
11.2.2. Market Revenue Forecast By Technology (2017-2030)
11.2.3. Market Revenue Forecast By Application (2017-2030)
11.2.4. Market Revenue Forecast by Technology (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue Forecast (2017-2030)
11.2.5.2. Market Revenue Forecast (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue Forecast (2017-2030)
11.2.6.2. Market Revenue Forecast (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue Forecast (2017-2030)
11.2.7.2. Market Revenue Forecast (2017-2030)
11.2.8. Rest of EU
11.2.8.1. Market Revenue Forecast (2017-2030)
11.2.8.2. Market Revenue Forecast (2017-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2017-2030)
11.3.2. Market Revenue Forecast By Technology (2017-2030)
11.3.3. Market Revenue Forecast By Application (2017-2030)
11.3.4. Market Revenue Forecast by Technology (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue Forecast (2017-2030)
11.3.5.2. Market Revenue Forecast (2017-2030)
11.3.6. India
11.3.6.1. Market Revenue Forecast (2017-2030)
11.3.6.2. Market Revenue Forecast (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue Forecast (2017-2030)
11.3.7.2. Market Revenue Forecast (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue Forecast (2017-2030)
11.3.8.2. Market Revenue Forecast (2017-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2017-2030)
11.4.2. Market Revenue Forecast By Technology (2017-2030)
11.4.3. Market Revenue Forecast By Application (2017-2030)
11.4.4. Market Revenue Forecast by Technology (2017-2030)
11.4.5. Brazil
11.4.5.1. Market Revenue Forecast (2017-2030)
11.4.5.2. Market Revenue Forecast (2017-2030)
11.4.6. Rest of LATAM
11.4.6.1. Market Revenue Forecast (2017-2030)
11.4.6.2. Market Revenue Forecast (2017-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2017-2030)
11.5.2. Market Revenue Forecast By Technology (2017-2030)
11.5.3. Market Revenue Forecast By Application (2017-2030)
11.5.4. Market Revenue Forecast by Technology (2017-2030)
11.5.5. GCC
11.5.5.1. Market Revenue Forecast (2017-2030)
11.5.5.2. Market Revenue Forecast (2017-2030)
11.5.6. North Africa
11.5.6.1. Market Revenue Forecast (2017-2030)
11.5.6.2. Market Revenue Forecast (2017-2030)
11.5.7. South Africa
11.5.7.1. Market Revenue Forecast (2017-2030)
11.5.7.2. Market Revenue Forecast (2017-2030)
11.5.8. Rest of MEA
11.5.8.1. Market Revenue Forecast (2017-2030)
11.5.8.2. Market Revenue Forecast (2017-2030)

Chapter 12. Company Profiles

12.1. Alere, Inc.
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2017-2021)
12.1.4. Recent Developments and Strategies
12.2. Hoffmann-La Roche Ltd.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2017-2021)
12.2.4. Recent Developments and Strategies
12.3. Arkray
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2017-2021)
12.3.4. Recent Developments and Strategies
12.4. Beckman Coulter
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2017-2021)
12.4.4. Recent Developments and Strategies
12.5. Becton Disckinson
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2017-2021)
12.5.4. Recent Developments and Strategies
12.6. Bio-Rad laboratories
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2017-2021)
12.6.4. Recent Developments and Strategies
12.7. bioMerieux S.A.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2017-2021)
12.7.4. Recent Developments and Strategies
12.8. Danaher
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2017-2021)
12.8.4. Recent Developments and Strategies
12.9. Sysmex Corporation
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2017-2021)
12.9.4. Recent Developments and Strategies
12.10. Abbott Laboratories
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2017-2021)
12.10.4. Recent Developments and Strategies
12.11. Company 11
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2017-2021)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2017-2021)
12.12.4. Recent Developments and Strategies

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

 You can place an order or ask any questions, please feel free to contact at [email protected] | +1 9197 992 333

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Blog: https://www.pharma-geek.com